Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 8

 Clinical Gastroenterology and Hepatology Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to TreatmentVolume 22, Issue 5P994-1004.E10May 2024This large-scale European study characterized the presentation and treatment effectiveness for Type 1 Autoimmune Pancreatitis (AIP), a condition where the immune system attacks the pancreas. Analyzing data from over 700 adults, the research found that corticosteroid treatment was highly effective, yielding a 79% complete remission rate among treated patients. The results suggest that for inducing remission, a relatively conservative regimen of 0.4 mg/kg/day of steroids for two weeks is sufficient, as more aggressive or higher doses offered no additional benefit. Notably, patients with elevated IgG4 levels required closer monitoring due to an independently decreased chance of achieving complete remission.